Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 20%Low 3 · 60%Moderate 1 · 20%High 0 · 0%

Histologic remission · Adult patients with active ulcerative colitis

Budesonide probably leads to lower histologic remission Gross 2011 compared with mesalamine (moderate certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.81 [0.66, 0.99]
1 study · 343 participants
Moderate

Histologic remission · Adult patients with active ulcerative colitis

It is very uncertain whether budesonide 10 mg changes histologic remission compared with prednisolone 40 mg (very low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 0.56 [0.15, 2.06]
1 study · 72 participants
Very low

Histologic remission · Adult patients with active ulcerative colitis

Budesonide MMX® 6 mg showed no clear difference in histologic remission compared with placebo (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.23 [0.63, 2.4]
2 studies · 440 participants
Low

Histologic remission · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg showed no clear difference in histologic remission compared with entocort EC 9mg (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.21 [0.64, 2.31]
1 study · 212 participants
Low

Histologic remission · Adult patients with active ulcerative colitis

Budesonide MMX® 9 mg may leads to higher histologic remission compared with placebo (low certainty).

1 finding from 1 review

Oral budesonide for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes only
RR 1.51 [1.11, 2.06]
3 studies · 900 participants
Low